[HTML][HTML] Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: A systematic review
D Jeremic, L Jiménez-Díaz, JD Navarro-López - Ageing research reviews, 2021 - Elsevier
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in ageing,
affecting around 46 million people worldwide but few treatments are currently available. The …
affecting around 46 million people worldwide but few treatments are currently available. The …
[HTML][HTML] Nutritional psychiatry: Towards improving mental health by what you eat
Does it matter what we eat for our mental health? Accumulating data suggests that this may
indeed be the case and that diet and nutrition are not only critical for human physiology and …
indeed be the case and that diet and nutrition are not only critical for human physiology and …
Polyphenols and neuroprotection: Therapeutic implications for cognitive decline
Dietary polyphenols have been the focus of major interest for their potential benefits on
human health. Several preclinical studies have been conducted to provide a rationale for …
human health. Several preclinical studies have been conducted to provide a rationale for …
[HTML][HTML] The safety of green tea and green tea extract consumption in adults–results of a systematic review
J Hu, D Webster, J Cao, A Shao - Regulatory toxicology and pharmacology, 2018 - Elsevier
A systematic review of published toxicology and human intervention studies was performed
to characterize potential hazards associated with consumption of green tea and its …
to characterize potential hazards associated with consumption of green tea and its …
[HTML][HTML] Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's …
Abstract Epigallocatechin-3-gallate (EGCG) is a candidate for treatment of Alzheimer's
disease (AD) but its inherent instability limits bioavailability and effectiveness. We found that …
disease (AD) but its inherent instability limits bioavailability and effectiveness. We found that …
Down syndrome
Trisomy 21, the presence of a supernumerary chromosome 21, results in a collection of
clinical features commonly known as Down syndrome (DS). DS is among the most …
clinical features commonly known as Down syndrome (DS). DS is among the most …
Down syndrome and the complexity of genome dosage imbalance
SE Antonarakis - Nature Reviews Genetics, 2017 - nature.com
Down syndrome (also known as trisomy 21) is the model human phenotype for all genomic
gain dosage imbalances, including microduplications. The functional genomic exploration of …
gain dosage imbalances, including microduplications. The functional genomic exploration of …
Natural antioxidant compounds as potential pharmaceutical tools against neurodegenerative diseases
Natural antioxidants are a very large diversified family of molecules classified by activity
(enzymatic or nonenzymatic), chemical-physical properties (eg, hydrophilic or lipophilic) …
(enzymatic or nonenzymatic), chemical-physical properties (eg, hydrophilic or lipophilic) …
GnRH replacement rescues cognition in Down syndrome
M Manfredi-Lozano, V Leysen, M Adamo, I Paiva… - Science, 2022 - science.org
At the present time, no viable treatment exists for cognitive and olfactory deficits in Down
syndrome (DS). We show in a DS model (Ts65Dn mice) that these progressive …
syndrome (DS). We show in a DS model (Ts65Dn mice) that these progressive …
Emerging evidence for astrocyte dysfunction in schizophrenia
Schizophrenia is a complex, chronic mental health disorder whose heterogeneous genetic
and neurobiological background influences early brain development, and whose precise …
and neurobiological background influences early brain development, and whose precise …